SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-002125
Filing Date
2023-01-23
Accepted
2023-01-23 07:20:14
Documents
16
Period of Report
2023-01-20
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 55988
2 ex99-1.htm EX-99.1 16100
3 ex99-2.htm EX-99.2 58047
4 ex99-1_001.jpg GRAPHIC 6849
  Complete submission text file 0001493152-23-002125.txt   380719

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE hrow-20230120.xsd EX-101.SCH 4149
6 XBRL DEFINITION FILE hrow-20230120_def.xml EX-101.DEF 27404
7 XBRL LABEL FILE hrow-20230120_lab.xml EX-101.LAB 37859
8 XBRL PRESENTATION FILE hrow-20230120_pre.xml EX-101.PRE 26021
10 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 6503
Mailing Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215
Business Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215 615.733.4731
HARROW HEALTH, INC. (Filer) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35814 | Film No.: 23542513
SIC: 2834 Pharmaceutical Preparations